https://biotechmorning.com/news/sanofi-caught-trash-talking-rival-vaccine Biotech Morning en 2026-10-14T14:18:32.342Z Sanofi Got Caught Trash-Talking a Rival Vaccine https://biotechmorning.com/news/glp1-graveyard-getting-crowded Biotech Morning en 2026-10-14T14:17:46.324Z The GLP-1 Graveyard Is Getting Crowded https://biotechmorning.com/news/zealand-generate-ai-obesity-protein-deal Biotech Morning en 2026-10-14T14:17:01.234Z Zealand Just Bet $1.2 Billion That AI Can Design the Next Obesity Drug https://biotechmorning.com/news/gsk-billion-dollar-idrx-gist-acquisition Biotech Morning en 2026-10-14T14:16:15.974Z GSK Just Spent $1 Billion on a Cancer You've Probably Never Heard Of https://biotechmorning.com/news/pfizer-enodia-protein-degradation-deal Biotech Morning en 2026-10-14T14:15:28.194Z Pfizer's Half-Billion-Dollar Bet on Killing Proteins Before They're Born https://biotechmorning.com/news/syndax-walks-away-ipf-lung-disease Biotech Morning en 2026-10-14T14:14:38.349Z Syndax Just Walked Away From a Billion-Dollar Lung Disease https://biotechmorning.com/news/otsuka-rexulti-ptsd-fda-adcom-skepticism Biotech Morning en 2026-10-14T14:13:51.027Z Otsuka's Big Bet on a PTSD Pill Just Hit a Wall at the FDA https://biotechmorning.com/news/keytruda-first-biosimilar-fda-review Biotech Morning en 2026-10-14T14:13:06.633Z The $32 Billion Drug That Just Got Its First Real Challenger https://biotechmorning.com/news/novartis-abogen-rna-deal Biotech Morning en 2026-10-14T14:12:26.585Z Novartis Just Bet $7.8 Billion That Your Body Can Build Its Own Medicine https://biotechmorning.com/news/gilead-vir-biotechnology-masked-tce-deal Biotech Morning en 2026-10-14T14:11:42.330Z Gilead Just Bet $1.9 Billion on a Cancer Drug That Wears a Disguise https://biotechmorning.com/news/vykat-xr-withdrawal-call-prader-willi Biotech Morning en 2026-10-13T14:17:40.455Z The First Drug for a Devastating Rare Disease Just Got a Public Takedown https://biotechmorning.com/news/roche-rona-rni-obesity-deal Biotech Morning en 2026-10-13T14:16:53.480Z Roche Just Paid $1.16 Billion for a Fat-Silencing Technology https://biotechmorning.com/news/novo-nordisk-300m-hengrui-oral-glp1-deal Biotech Morning en 2026-10-13T14:16:03.595Z Novo Nordisk Just Paid $300M for a Pill That Doesn't Exist Yet https://biotechmorning.com/news/bms-ryz101-action-1-gep-nets-radiopharmaceutical-win Biotech Morning en 2026-10-13T14:15:18.364Z BMS Just Made a $4.1 Billion Bet Pay Off https://biotechmorning.com/news/sanofi-regeneron-8-billion-immunology-expansion Biotech Morning en 2026-10-13T14:14:35.759Z Pharma's Longest-Running Power Couple Just Doubled Down https://biotechmorning.com/news/daiichi-sankyo-merck-adc-bla-withdrawal-sclc Biotech Morning en 2026-10-13T14:13:49.973Z A $22 Billion Bet Just Hit Its First Big Speed Bump https://biotechmorning.com/news/bms-admilparant-ipf-mixed-results Biotech Morning en 2026-10-13T14:13:04.826Z BMS's Lung Scarring Drug Passed Its Biggest Test. Then Things Got Complicated. https://biotechmorning.com/news/biontech-mrna-cancer-vaccine-phase-3-miss Biotech Morning en 2026-10-13T14:12:19.134Z BioNTech's Big Bet on mRNA Cancer Vaccines Just Hit a Wall